| SANDOSTATIN 500 microgram/1 ml, solution for injection/infusion PA0896/028/003 |
Octreotide |
Novartis Ireland Limited |
Marketed |
| Sandostatin LAR 10 mg powder and solvent for suspension for injection PA0896/028/004 |
Octreotide |
Novartis Ireland Limited |
Marketed |
| Sandostatin LAR 10 mg powder and solvent for suspension for injection PPA0465/514/001 |
Octreotide |
PCO Manufacturing Ltd. |
— |
| Sandostatin LAR 20 mg powder and solvent for suspension for injection PA0896/028/005 |
Octreotide |
Novartis Ireland Limited |
Marketed |
| Sandostatin LAR 20 mg powder and solvent for suspension for injection PPA0465/514/002 |
Octreotide |
PCO Manufacturing Ltd. |
— |
| Sandostatin LAR 30 mg powder and solvent for suspension for injection PA0896/028/006 |
Octreotide |
Novartis Ireland Limited |
Marketed |
| Sandostatin LAR 30 mg powder and solvent for suspension for injection PPA0465/514/003 |
Octreotide |
PCO Manufacturing Ltd. |
— |
| Sanomigran 1.5mg Tablets PA1113/012/002 |
Pizotifen |
Phoenix Labs |
Not marketed |
| Sanomigran 500 microgram Tablets PA1113/012/001 |
Pizotifen |
Phoenix Labs |
Not marketed |
| Saphnelo 300 mg Concentrate for solution for infusion EU/1/21/1623/001 |
Anifrolumab |
AstraZeneca AB |
— |
| Sapropterin Dipharma 100 mg Soluble tablet EU/1/21/1620/001-003 |
Sapropterin hydrochloride |
Dipharma Arzneimittel GmbH |
— |
| Sapropterin Dipharma 500 mg Powder for oral solution EU/1/21/1620/004 |
Sapropterin hydrochloride |
Dipharma Arzneimittel GmbH |
— |
| SARCLISA 20 mg/mL concentrate for solution for infusion EU/1/20/1435/001-003 |
Isatuximab |
Sanofi Winthrop Industrie |
— |
| Sastravi 100mg/25mg/200mg Film-coated Tablets PA1986/120/003 |
Levodopa, Carbidopa, Entacapone |
Teva B.V. |
Marketed |
| Sastravi 125mg/31.25mg/200mg Film-coated Tablets PA1986/120/004 |
Levodopa, Carbidopa, Entacapone |
Teva B.V. |
Marketed |
| Sastravi 150mg/37.5mg/200mg Film-coated Tablets PA1986/120/005 |
Levodopa, Carbidopa, Entacapone |
Teva B.V. |
Marketed |
| Sastravi 175mg/43.75mg/200mg Film-coated Tablets PA1986/120/006 |
Levodopa, Carbidopa, Entacapone |
Teva B.V. |
Marketed |
| Sastravi 200mg/50mg/200mg Film-coated Tablets PA1986/120/007 |
Levodopa, Carbidopa, Entacapone |
Teva B.V. |
Marketed |
| Sastravi 50mg/12.5mg/200mg Film-coated Tablets PA1986/120/001 |
Levodopa, Carbidopa, Entacapone |
Teva B.V. |
Marketed |
| Sastravi 75mg/18.75mg/200mg Film-coated Tablets PA1986/120/002 |
Levodopa, Carbidopa, Entacapone |
Teva B.V. |
Marketed |
| Sativex oromucosal spray PA25377/001/001 |
Delta-9-tetrahydrocannabinol botanical drug substance (thc bds), CANNABIDIOL |
CNX Therapeutics Ireland Limited |
Marketed |
| Savene 20 mg/ml powder and solvent for concentrate for solution for infusion EU/1/06/350/001 |
Dexrazoxane |
CNX Therapeutics Ireland Limited |
— |
| Savlon Antiseptic Cream Cetrimide 0.5% w/w Chlorhexidine Digluconate 0.1% w/w PA0126/324/002 |
Cetrimide, Chlorhexidine gluconate |
Clonmel Healthcare Ltd |
Marketed |
| Savlon Antiseptic Liquid PA0678/139/001 |
Chlorhexidine gluconate, Cetrimide |
Haleon Ireland Limited |
Not marketed |
| Saxenda 6 mg/ml solution for injection in pre-filled pen EU/1/15/992/001-003 |
Liraglutide |
Novo Nordisk A/S |
— |
| Scandonest 3% w/v Solution for Injection PA0196/015/001 |
Mepivacaine hydrochloride |
Septodont |
Marketed |
| Scemblix 20 mg film-coated tablets EU/1/22/1670/001-002 |
Asciminib hydrochloride |
Novartis Europharm Limited |
— |
| Scemblix 40 mg film-coated tablets EU/1/22/1670/003-004 |
Asciminib hydrochloride |
Novartis Europharm Limited |
— |
| SCENESSE 16 mg implant EU/1/14/969/001 |
Afamelanotide |
Clinuvel Europe Limited |
— |
| Scheriproct 1 mg + 1 mg suppositories PA22650/005/002 |
Prednisolone, Cinchocaine Hydrochloride |
Karo Pharma AB |
Marketed |
| Scheriproct 1.5 mg/g + 5 mg/g rectal ointment PA22650/005/001 |
Prednisolone caproate, Cinchocaine Hydrochloride |
Karo Pharma AB |
Marketed |
| Scintimun 1 mg kit for radiopharmaceutical preparation EU/1/09/602/1-2 |
Besilesomab |
Telix Innovations |
— |
| Seebri Breezhaler 44 micrograms inhalation powder, hard capsules EU/1/12/788/001-006 |
Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| Seffalair Spiromax 12.75 micrograms/100 micrograms inhalation powder EU/1/21/1533/001-002 |
SALMETEROL XINAFOATE, Fluticasone propionate |
Teva B.V. |
— |
| Seffalair Spiromax 12.75 micrograms/202 micrograms inhalation powder EU/1/21/1533/003-004 |
SALMETEROL XINAFOATE, Fluticasone propionate |
Teva B.V. |
— |
| Segluromet 2.5 mg/1 000 mg film-coated tablets EU/1/18/1265/008-014 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride |
Merck Sharp & Dohme BV |
— |
| Segluromet 2.5 mg/850 mg film-coated tablets EU/1/18/1265/001-007 |
Metformin Hydrochloride, Ertugliflozin l-pyroglutamic acid |
Merck Sharp & Dohme BV |
— |
| Segluromet 7.5 mg/1 000 mg film-coated tablets EU/1/18/1265/022-028 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride |
Merck Sharp & Dohme BV |
— |
| Segluromet 7.5 mg/850 mg film-coated tablets EU/1/18/1265/015-021 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride |
Merck Sharp & Dohme BV |
— |
| SeHCAT 370kBq capsules PA22661/001/001 |
Tauroselcholic acid |
GE Healthcare Buchler GmbH & Co KG |
Marketed |
| Selesyn 100 micrograms/2 ml, oral solution (50 micrograms/ml) PA1131/001/001 |
Sodium selenite pentahydrate |
biosyn Arzneimittel GmbH |
Marketed |
| Selesyn 100 micrograms/2 ml, solution for injection (50 micrograms/ml) PA1131/001/003 |
Sodium selenite pentahydrate |
biosyn Arzneimittel GmbH |
Marketed |
| Selesyn 500 micrograms/10 ml, oral solution (50 micrograms/ml) PA1131/001/002 |
Sodium selenite pentahydrate |
biosyn Arzneimittel GmbH |
Not marketed |
| Selesyn 500 micrograms/10 ml, solution for injection (50 micrograms/ml) PA1131/001/004 |
Sodium selenite pentahydrate |
biosyn Arzneimittel GmbH |
Not marketed |
| Selexipag Accord 1 000 microgram film-coated tablets PA2315/281/005 |
Selexipag |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Selexipag Accord 1 200 microgram film-coated tablets PA2315/281/006 |
Selexipag |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Selexipag Accord 1 400 microgram film-coated tablets PA2315/281/007 |
Selexipag |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Selexipag Accord 1 600 microgram film-coated tablets PA2315/281/008 |
Selexipag |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Selexipag Accord 200 microgram film-coated tablets PA2315/281/001 |
Selexipag |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Selexipag Accord 400 microgram film-coated tablets PA2315/281/002 |
Selexipag |
Accord Healthcare Ireland Ltd. |
Not marketed |